ArtiQ

About:

ArtiQ developed AI-based software to help doctors save time & improve interpretation of lung function tests & diagnosis of lung diseases

Website: https://www.artiq.eu/

Twitter/X: artiqhealth

Top Investors: KBC, Gemma Frisius Fund

Description:

ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). Company is founded in early 2019 by four committed founders with a long history in respiratory medicine, medical devices and artificial intelligence. Working on a junction of multidisciplinary fields, founders identified opportunity and value that novel technologies could bring to all parties in a respiratory setting: patients, doctors, healthcare system and industry. ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With the first developed artificial intelligence-based medical software, ArtiQ is already helping interpretation of pulmonary function tests and improving lung disease diagnostic environment.